期刊文献+

PCR-SSCP分析急性淋巴细胞白血病TCR基因寡/亚克隆重排及临床意义 被引量:8

The study of oligoclonal/subclonal rearrangement of TCR gene in acute lymphoblastic leukemia with PCR-SSCP and it′s clinical significance
原文传递
导出
摘要 目的 为研究急性淋巴细胞白血病 (ALL)TCR基因寡 /亚克隆重排及与临床关系。方法 采用PCR SSCP技术分析 81例ALLTCRVγⅠ Jγ基因重排。结果  65例 ( 80 .2 % )ALL病人存在TCRVγⅠ Jγ基因重排 ,8例 ( 8.6% )病人存在寡 /亚克隆重排 ;寡 /亚克隆ALL的白细胞计数显著高于非寡 /亚克隆ALL(P <0 .0 1 ) ;寡 /亚克隆ALL的完全缓解率为 3 7.5% ,显著低于非寡 /亚克隆ALL( 80 .7% ) (P <0 .0 0 5)。结论 应用PCR SSCP方法可确定ALL的寡 /亚克隆性 ,ALL病人寡 /亚克隆检测有助于预测疗效和预后判断。 Objective To study the oligoclonal/subclonal rearrangement of T cell receptor (TCR) gene in the patients of acute lymphoblastic leukemia (ALL) and its relationship to the clinical characteristics. Methods TCR VγⅠ Jγ gene rearrangement were detected in 81 cases by polymerase chain reaction (PCR) and single strand conformation polymorphism (SSCP). Results 65 cases (80.2%) were found with TCR VγⅠ Jγ gene rearrangement and 8 cases (8.6%) showed oligoclonal/subclonal rearrangement. The leucocyte count were higher in ALL patients with oligoclonal/subclonal rearrangement than the ALL patients without oligoclonal/subclonal rearrangement ( P <0.01). 37.5% oligoclonal/subclonal rearrangement ALL patients achieved complete remission, which was significantly lower than that (80.7%) in ALL case without oligoclonal/subclonal rearrangement. Conclusion Detection of TCR γ gene rearrangement by PCR SSCP can identify oligoclonality/subclonality in ALL patients and oligoclonal/subclonal rearrangement was potential in predicting prognosis of ALL.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2001年第5期494-496,共3页 Chinese Journal of Microbiology and Immunology
基金 广东省科技攻关基金资助 ( 99M0 4 91 1G)
关键词 急性淋巴细胞白血病 T细胞受体 寡/亚克隆重排 聚合酶链反应 单链构象多态性 Acute lymphoblastic leukemia T cell receptor Oligoclonal/subclonal rearrangement Polymerase chain reaction Single strand conformation polymorphism
  • 相关文献

参考文献2

  • 1徐兵,中华医学杂志,1996年,76卷,552页
  • 2陆道培,白血病治疗学,1992年,5页

同被引文献51

  • 1SenGupta DN, Zmudzka BZ, Kumar P, et al. Sequence of human DNA polymerase beta mRNA obtained through cDNA cloning. Biochem Biophys Res Commun, 1986,136(1) :341.
  • 2Estrov Z, Freedman MH. Detection of residual disease in acute lymphobiastic leukemia of childhood. Leuk Lymphoma, 1999,33 (1 - 2) : 47~ 52.
  • 3Bfisco M J, Condon J, Hughes E, et al. Outcome prediction in childhood acute lymphoblastic leukemia by molecular quantification of residual disease at the end of induction. Lancet, 1994,343(8891 ):196- 200.
  • 4Martin G, Mairs RJ. Synthesis of quantitation standards for nested completitive PCR for the determination of mininal residual disease in B - lineage acute lymphohlastic leukaemia. Leuk Res, 1997,21 (9) : 807 -809.
  • 5Tarusawa M, Yashima A, Endo M, et al. Quantitative assessment of minimal residual disease in childhood lymphoid malignancies using an allele - specific oligonucleotide real time quantitative polymerase chain reaction, Int J Hematol, 2002,75(2) : 166 - 173.
  • 6Sathe GM, Brien S O, McLaughlin MM, et al. Use of polymerase chain reaction for rapid detection of gene insertions in whole yeast cells[J]. Nucleic Acids Res, 1991,19:47751.
  • 7Chomel JC, Brizard F, Veinstein A, et al. Persistance of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interfern-alpha therapy or allogeneic bone marrow transplantation. Blood, 200
  • 8van der Velden VH, Hochhaus A, Cazzaniga G, et al. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leokemia,2003,17(6): 1013 - 1034
  • 9Kreuzer KA, Lass U, Bohn A, et al. LightCycler technology for the quantitation of bcr/abl fusion transcripts. Cancer Res, 1999, 59(13):3171 - 3174
  • 10Gelmini S, Orlando C, Sestini R, et al. Quantitative polymerase chain reaction-based homogeneous assay with fluorogenic probes to measure cerbB-2 oncogene amplification. Clin Chem, 1997,43(5):752- 758

引证文献8

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部